Membership
Member Benefits Lapse Soon
If you did not renew your membership for 2023, there's still time. Renew to stay connected to your global community and keep access to your exclusive member benefits.
Renew Now
Registration for ENDO 2023 is now open! Early registration pricing expires on March 8. Reserve your space to join us at the signature meeting in endocrinology this June at the best possible rates.
If you did not renew your membership for 2023, there's still time. Renew to stay connected to your global community and keep access to your exclusive member benefits.
Renew Now
The first issue of JCEM Case Reports is now available! Case reports can deepen our understanding of endocrine disorders, enhance clinical skills, and suggest useful areas for research. JCEM Case Reports is launching with six issues per year and will operate within a continuous, online publication model.
Read Now
We recently launched an online-only, open-access journal called JCEM Case Reports. Listen as JCEM Case Reports Editor-in-Chief William F. Young Jr., MD, discusses what we can learn from case studies and what our new journal has to offer.
Tune in Today
DocMatter has become the go-to space for a global community of endocrinology professionals to collaborate. Ben Wokas, Senior Manager of Member Engagement & Experience and Membership & Diversity Programs, provides a DocMatter 101 primer, describing what it is, how it works, and what can you expect from joining the online community.
Read Now.jpg?la=en&h=126&w=240&mw=240&hash=DDA37CF39B67CD45F836C9E5BF0842F2)
Diabetes care is one of the most in-demand skills in endocrinology. However, keeping up with the latest treatments can be challenging. Expand your knowledge by enrolling in our Diabetes Certificate Program. This self-paced course is centered around 12 modules covering medical therapy options for insulin and non-insulin treatments. Learn innovative approaches to care delivery with new technology and therapeutic options and more. Enroll now!
Learn More
Join host Chase Hendrickson, MD, as he discusses a recent JCEM article with Ashok Balasubramanyam, MD, and David Nathan, MD. The article featured for this episode is “Clinical and Safety Outcomes With GLP-1 Receptor Agonists and SGLT2 Inhibitors in Type 1 Diabetes: A Real-World Study.”
Listen Now
Read our special collection of journal articles, published in 2021–2022, focused on adrenal disease! Curation of the collection was guided by Altmetric Attention Scores and Featured Article designations.
Read More
Interested in staying informed with the latest endocrinology research? Follow @EndoSocJournals for top-quality articles from #JCEM, #Endocrinology, #JES, and #EndocrineReviews.
Follow @EndoSocJournals
Cover Story: People with diabetes have an increased risk of fractures, which is often underdiagnosed and impacts their mobility as well as their mortality. A new array of treatments and assessments — novel therapeutics, senolytics, revamped prescribing protocols, and more — are needed to better concentrate on diabetic bone disease. An emerging complication of both type 1 and type 2 diabetes is confounding clinicians and prompting new research into its pathophysiology as well as its prevention and treatment: increased fracture risk as a result of bone fragility. In older adults, this risk is compounded by the risk for falls and fractures inherent to their age.
The Endocrine Society holds many webinars throughout the year on a wide range of topics. Check here for upcoming webinars and links to previous events.
View our Worldwide Endocrinology Calendar for a listing of both domestic and international meetings. If you have a meeting you would like to be included, submit it to us.
Join our endocrine community and become a member! Only members receive access to a variety of member benefits that will enhance your career. If your membership has lapsed, rejoin today so that you can continue to receive your membership benefits.
Read our special collections of Endocrine Society journal articles, curated by topic, Altmetric Attention Scores, and Featured Article designations.
Advertisement